AMCP webinar that addressed what is currently being seen in the industry and how to effectively support and continue this early, meaningful, and effective exchange of information for pre-approval products.

AMCP has released Version 4.1 of the AMCP Format for Formulary Submissions, which includes two new dossier types for biopharmaceutical manufacturers to share evidence on unapproved products and new indications that are under review by the U.S. Food and Drug Administration (FDA).

AMCP webinar that provided insights around the evolution of the pre-approval information exchange between manufacturers and payers.

AMCP webinar that reviewed the current pre-approval support features within FormuarlyDecisions.com and insights from the active FormularyDecisions.com Payer community.

AMCP webinar that discussed the current state of payer perceptions regarding dossier timing, quality and use as well as future considerations for improving dossier relevancy and optimization of use.

AMCP webinar that discussed the significance of the shifting landscape and the dilemmas of the FDA accelerated approval process.

Press Release: "Precision medicine is no longer emerging, it's happening now," according to Susan A. Cantrell, RPh, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP).